IO Biotech Inc
NASDAQ:IOBT
IO Biotech Inc
NASDAQ:IOBT
Price:
1.54 USD
3.36%
Market Closed
Updated:
May 8, 2024
IO Biotech Inc
Cash from Financing Activities
|
IO Biotech Inc
Cash from Financing Activities Peer Comparison
Comparables:
GMAB
ZEAL
ASND
B
BAVA
BIOPOR
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
IO Biotech Inc
NASDAQ:IOBT
|
Cash from Financing Activities
$71.9m
|
CAGR 3-Years
142%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Genmab A/S
CSE:GMAB
|
Cash from Financing Activities
-kr606m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-54%
|
CAGR 10-Years
N/A
|
|
|
Zealand Pharma A/S
CSE:ZEAL
|
Cash from Financing Activities
kr907m
|
CAGR 3-Years
6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ascendis Pharma A/S
NASDAQ:ASND
|
Cash from Financing Activities
€135m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Cash from Financing Activities
kr735.8m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
Bioporto A/S
CSE:BIOPOR
|
Cash from Financing Activities
kr40.8m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-2%
|
See Also
What is IO Biotech Inc's Cash from Financing Activities?
Cash from Financing Activities
71.9m
USD
71.9m
USD
Based on the financial report for Dec 31, 2023, IO Biotech Inc's Cash from Financing Activities amounts to 71.9m USD.
What is IO Biotech Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
142%
142%
The average annual Cash from Financing Activities growth rates for IO Biotech Inc have been 142% over the past three years .
You don't have any saved screeners yet
